热门资讯> 正文

ProMIS神经科学GAAP每股收益为-0.29美元

2025-08-13 22:27

ProMIS Neurosciences press release (NASDAQ:PMN): Q2 GAAP EPS of -$0.29.
Cash and cash equivalents were $4.5 million as of June 30, 2025, compared to $1.0 million as of June 30, 2024.

More on ProMIS Neurosciences

ProMIS Neurosciences raises $3.2M through ATM offering, PIPE financing
Seeking Alpha’s Quant Rating on ProMIS Neurosciences
Historical earnings data for ProMIS Neurosciences
Financial information for ProMIS Neurosciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。